Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Opus Genetics, Inc. (IRD)

Autolus Therapeutics PLC Sponsored ADR and Opus Genetics, Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Opus Genetics, Inc. are of similar size ($335.4M and $333.2M). Autolus Therapeutics PLC Sponsored ADR grew revenue faster over the last twelve months: 193.3% against −36.1%. Autolus Therapeutics PLC Sponsored ADR has the higher net margin (−238.7% vs −1,091.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Autolus Therapeutics PLC Sponsored ADR leads on 9 and Opus Genetics, Inc. on 6.

Valuation

Metric AUTL IRD Biotechnology median
P/E n/m n/m 10.60
P/S 2.90 40.40 9.40
P/B 4.55 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.83 34.95 9.02
Earnings yield (82.81%) (30.94%) (32.88%)
Free cash flow yield (74.52%) (10.61%) (23.13%)

Profitability

Metric AUTL IRD Biotechnology median
Gross margin 15.66% 100.00% 68.51%
Operating margin (210.78%) (513.47%) 0.00%
Net margin (238.66%) (1,091.82%) 0.00%
Free cash flow margin (198.26%) (412.61%) 0.00%
Return on equity (133.00%) (4,796.52%) (51.96%)
Return on assets (46.15%) (163.50%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AUTL IRD Biotechnology median
Revenue growth (TTM) 193.29% (36.09%) 6.76%
EPS growth (last fiscal year) (25.58%) 62.79% 29.88%
Revenue growth, 5-year CAGR 113.11% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUTL IRD Biotechnology median
Debt to equity 1.04 (2.69) 0.00
Current ratio 4.89 12.19 4.97
Net debt to EBITDA 1.16 1.17 1.01

Dividend

Metric AUTL IRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AUTL IRD Biotechnology median
Market cap 335.36m 333.20m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack